Cargando…
Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function
Myocardial infarction is one of the leading causes of mortality and morbidity worldwide. Whereas transplantation of several cell types into the infarcted heart has produced promising preclinical results, clinical studies using analogous human cells have shown limited structural and functional benefi...
Autores principales: | Rannou, Alice, Toumaniantz, Gilles, Larcher, Thibaut, Leroux, Isabelle, Ledevin, Mireille, Hivonnait, Agnès, Babarit, Candice, Fleurisson, Romain, Dubreil, Laurence, Ménoret, Séverine, Anegon, Ignacio, Charpentier, Flavien, Rouger, Karl, Guével, Laetitia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364022/ https://www.ncbi.nlm.nih.gov/pubmed/32695846 http://dx.doi.org/10.1016/j.omtm.2020.06.009 |
Ejemplares similares
-
Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation
por: Robriquet, Florence, et al.
Publicado: (2016) -
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation
por: Robriquet, Florence, et al.
Publicado: (2015) -
Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits
por: Lorant, Judith, et al.
Publicado: (2018) -
Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches
por: Saury, Charlotte, et al.
Publicado: (2018) -
Specific and label-free endogenous signature of dystrophic muscle by Synchrotron deep ultraviolet radiation
por: Dubreil, Laurence, et al.
Publicado: (2023)